P3 Health Partners Inc.
P3 Health Partners Inc. (PIII) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
piii · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for P3 Health Partners Inc. (PIII) measures how much investors pay for each dollar of the company's trailing earnings. PIII's current PE ratio of N/A is calculated by dividing its stock price of $12.25 by its TTM earnings per share of -$38.40.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2018 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
P3 Health Partners Inc.You PIII | $40M | N/A | — | -$38.40 |
 Basel Medical Group Ltd Ordinary Shares BMGL | $11M | N/A | — | $0.00 |
 Hyperion DeFi, Inc. HYPD | $15M | N/A | — | -$9.06 |
 iBio, Inc. IBIO | $27M | N/A | — | -$1.75 |
 Intensity Therapeutics, Inc. INTS | $7M | N/A | — | -$0.86 |
 Iterum Therapeutics plc ITRM | $2M | N/A | — | -$1.26 |
 Plus Therapeutics, Inc. PSTV | $13M | N/A | — | -$7.19 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-45.26 | — | |
2024-12-31 FY2024 | — | $-46.78 | — | |
2023-12-31 FY2023 | — | $-30.44 | — | |
2022-12-31 FY2022 | — | $-324.84 | — | |
2021-12-31 FY2021 | — | $-188.17 | — | |
2020-12-31 FY2020 | — | $-39.73 | — | |
2019-12-31 FY2019 | — | $-88.20 | — | |
2018-12-31 FY2018 | — | $-92.04 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for P3 Health Partners Inc. (PIII) measures how much investors pay for each dollar of the company's trailing earnings. PIII's current PE ratio of N/A is calculated by dividing its stock price of $12.25 by its TTM earnings per share of -$38.40.
Frequently asked questions
PIII pe ratio · 6 questionsPIII's current PE ratio is N/A as of 2026-06-08, based on a stock price of $12.25 and TTM EPS of -$38.40. Data sourced from Financial Modeling Prep via PIII's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · P3 Health Partners Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08